Phase 2 trial of the cyclin‐dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein‐expressing germ cell tumors

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|9|1463-1468

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.9, 2015-05, pp. : 1463-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma

By  

Oncology, Vol. 59, Iss. 1, 2000-06 ,pp. : 68-74

Karger

Access to resources Recommend Favorite

An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 976-982

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury

By            

International Journal of Molecular Medicine, Vol. 34, Iss. 3, 2014-01 ,pp. : 911-917

Spandidos Publications

Access to resources Recommend Favorite

O‐06: Naturally occurring novel mutation in Cterminal region of Hepatitis B virus X protein promotes proliferation of hepatoma cells through up‐regulating miR‐221 targeting cyclin‐dependent kinase inhibitor (CDKI)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 4-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gonadal Function in Patients with Testicular Germ Cell Tumors

By Tomomasa H.   Oshio S.   Ashizawa Y.   Kamiyama Y.   Okano Y.   Iiyama T.   Sato S.   Shimizu H.   Umeda T.  

Archives of Andrology, Vol. 48, Iss. 6, 2002-11 ,pp. : 405-415

Informa Healthcare

Access to resources Recommend Favorite